CBD & Cancer: The COM-Scale Scientific Evidence Project by Krisztian Smith – Indiegogo
Crowdfunded cannabis research projects focusing on CBD and cancer are gaining attention but often lack rigorous scientific oversight. This article reviews the COM-Scale Scientific Evidence Project by Krisztian Smith. Clinicians should carefully evaluate…
Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav
Jazz Pharmaceuticals is advancing pharmaceutical grade CBD research with new findings on Epidiolex and Xywav. This research helps establish evidence-based dosing protocols and safety profiles. Such data is critical for broader cannabinoid medicine…
Hawaii Lawmakers Approve Bill To Create Psychedelics Task Force
Hawaii lawmakers have approved a bill to create a psychedelics task force study focused on psilocybin and MDMA. This task force will examine therapeutic applications and regulatory considerations. The study reflects growing interest in psychedelic…
Marijuana Rescheduling Countdown: Why the “Order of Operations” and Todd Blanche’s Role Matter
The marijuana rescheduling countdown highlights critical regulatory changes that could accelerate clinical trial timelines. This shift aims to remove barriers delaying Phase II and III studies, enabling better evidence-based cannabis therapies.…
Largest-ever Psychedelics Study Could Advance Use in Treating Mental Health Disorders
The largest psychedelic research mental health study marks a critical step toward evidence-based psychiatric care. This large-scale study aims to identify which patients benefit most from psychedelics. It could establish standardized protocols for…
Here’s What Psychedelics Actually Do to the Brain
Psychedelics neuropharmacology mental health research is advancing as these compounds enter clinical trials for treatment-resistant conditions. Understanding their brain effects is crucial for clinicians counseling patients. This emerging field offers…
Medical Marijuana’s Growing Role in Clinical Trials
Medical cannabis clinical trials are increasing, marking a shift toward evidence-based cannabis medicine. This growth supports clinicians in making informed treatment decisions. The focus on rigorous trials enhances understanding of cannabis’s…
Wall Street Zen Upgrades Cardiol Therapeutics to Hold – Sioux City Today
Wall Street Zen recently upgraded Cardiol Therapeutics to Hold, reflecting market confidence in cannabidiol cardiovascular therapeutics. This upgrade signals potential progress in cannabidiol cardiovascular clinical trials. Clinicians should monitor…
CU Boulder and CSU Collaborate to Share Cannabis Research Facilities
Academic research partnerships cannabis between CU Boulder and CSU are set to accelerate cannabis research by pooling resources and expertise. This collaboration addresses long-standing infrastructure gaps in cannabis clinical research. Such partnerships…
How Marijuana Rescheduling Could Unlock Research for Rare Diseases
Marijuana rescheduling research regulatory shift would remove key barriers to clinical trials for rare pediatric diseases. This change enables rigorous studies that families and clinicians have long awaited. It is a critical step toward evidence-based…